| Ethics, Human Use, and the Department of Defense Serum Repository. |
26444892
|
Pavlin JA, Welch RA |
Mil Med |
2015 |
MACS |
| Maximizing the Utility of the Serum Repository With Current Technologies and Recommendations to Meet Future Needs: Report of the Technical Panel. |
26444890
|
Baird CP |
Mil Med |
2015 |
MACS |
| A Brief Description of the Operation of the DoD Serum Repository. |
26444888
|
Perdue CL, Eick-Cost AA, Rubertone MV |
Mil Med |
2015 |
MACS |
| Description and utilization of the United States department of defense serum repository: a review of published studies, 1985-2012. |
25723497
|
Perdue CL, Cost AA, Rubertone MV, Lindler LE, Ludwig SL |
PLoS One |
2015 |
MACS |
| Cyst fluid biomarkers for intraductal papillary mucinous neoplasms of the pancreas: a critical review from the international expert meeting on pancreatic branch-duct-intraductal papillary mucinous neoplasms. |
25592469
|
Maker AV, Carrara S, Jamieson NB, Pelaez-Luna M, Lennon AM, Dal Molin M, Scarpa A, Frulloni L, Brugge WR |
J Am Coll Surg |
2015 |
PLCO |
| Genome-wide association study of survival in patients with pancreatic adenocarcinoma. |
23180869
|
Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault MC, Buring JE, Canzian F… |
Gut |
2014 |
PLCO |
| Culturally sensitive approaches to recruitment and retention of Hispanics in the national lung screening trial. |
23780349
|
Tenorio SL, O'Donnell CI, Hernandez J, Rozjabek HM, Lynch D, Marcus PM |
J Immigr Minor Health |
2014 |
NLST |
| Overdiagnosis in low-dose computed tomography screening for lung cancer. |
24322569
|
Patz EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR, NLST Overdiagnosis Manuscript Writing Team |
JAMA Intern Med |
2014 |
NLST |
| LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. |
24316677
|
Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE |
Epigenetics |
2014 |
PLCO |
| Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial. |
24053621
|
Pinsky PF, Parnes HL, Andriole G |
BJU Int. |
2014 |
PLCO |
| Body mass index and mortality among blacks and whites adults in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. |
23512729
|
Xiao Q, Hsing AW, Park Y, Moore SC, Matthews CE, Berrington de González A, Kitahara CM |
Obesity (Silver Spring) |
2014 |
PLCO |
| National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. |
25199624
|
Pinsky PF, Gierada DS, Hocking W, Patz EF, Kramer BS |
Ann. Intern. Med. |
2014 |
NLST |
| Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. |
25192282
|
O'Grady TJ, Kitahara CM, DiRienzo AG, Boscoe FP, Gates MA |
PLoS ONE |
2014 |
NLST, PLCO |
| The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. |
25089376
|
Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP, International Early Lung Cancer Investigators |
Eur. J. Cancer Prev. |
2014 |
NLST |
| Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. |
25065710
|
Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C |
Cancer |
2014 |
NLST |
| Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. |
25044253
|
Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y |
Urol. Oncol. |
2014 |
NLST, PLCO |
| Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. |
24979231
|
McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ |
PLoS ONE |
2014 |
NLST |
| CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. |
24955929
|
Yip R, Henschke CI, Yankelevitz DF, Smith JP |
Radiology |
2014 |
NLST |
| Impact of lung cancer screening results on smoking cessation. |
24872540
|
Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL |
J. Natl. Cancer Inst. |
2014 |
NLST |
| Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT. |
24755313
|
Pinsky PF, Nath PH, Gierada DS, Sonavane S, Szabo E |
Cancer Prev Res (Phila) |
2014 |
NLST |
